MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹185 Cr | ₹184 Cr | ₹170 Cr | ₹45 Cr | ₹48 Cr |
What is the latest Contingent Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹185 Cr |
| Mar2024 | ₹184 Cr |
| Mar2023 | ₹170 Cr |
| Mar2022 | ₹45 Cr |
| Mar2021 | ₹48 Cr |
How is Contingent Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹185 Cr | 0.84 | |
| Mar2024 | ₹184 Cr | 8.01 | |
| Mar2023 | ₹170 Cr | 273.61 | |
| Mar2022 | ₹45 Cr | -4.80 | |
| Mar2021 | ₹48 Cr | - | |
Compare Contingent Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹450.6 Cr | 0.6% | 16.9% | 6.4% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,472.1 Cr | 0.3% | 9.1% | -20.9% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,960.0 Cr | 2.5% | 21.8% | -35.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,232.1 Cr | 4.4% | 30.5% | -7.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,033.1 Cr | -3.6% | 46.1% | -27.8% | Stock Analytics | |
| INDO US BIOTECH | ₹210.6 Cr | 2.5% | 4.9% | -39.3% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | 0.6% |
16.9% |
6.4% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses